ATE495749T1 - Zusammensetzung für selektive hemmung der serotoninwiederaufnahme und verfahren dafür - Google Patents

Zusammensetzung für selektive hemmung der serotoninwiederaufnahme und verfahren dafür

Info

Publication number: ATE495749T1
Authority: AT; Austria
Prior art keywords: composition; serotonin reuptake; extract; relates; reuptake inhibition
Prior art date: 2007-02-12

Application number

AT08720152T

Other languages

English (en)

Inventor

Sunil Bhaskaran

Mohan Vishwaraman

Original Assignee

Indus Biotech Private Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-12

Filing date

2008-02-11

Publication date

2011-02-15

2008-02-11 Application filed by Indus Biotech Private Ltd filed Critical Indus Biotech Private Ltd

2011-02-15 Application granted granted Critical

2011-02-15 Publication of ATE495749T1 publication Critical patent/ATE495749T1/de

Links

230000005764 inhibitory process Effects 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 4
230000000697 serotonin reuptake Effects 0.000 title abstract 4
238000000034 method Methods 0.000 title abstract 3
QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 abstract 4
239000002904 solvent Substances 0.000 abstract 3
WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 abstract 2
BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 abstract 2
BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 abstract 2
WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 abstract 2
229940022757 asiaticoside Drugs 0.000 abstract 2
229930182470 glycoside Natural products 0.000 abstract 2
229940090813 madecassoside Drugs 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
239000000546 pharmaceutical excipient Substances 0.000 abstract 2
-1 terpenoid glycosides Chemical class 0.000 abstract 2
244000146462 Centella asiatica Species 0.000 abstract 1
229930002875 chlorophyll Natural products 0.000 abstract 1
235000019804 chlorophyll Nutrition 0.000 abstract 1
ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 abstract 1
239000003086 colorant Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004128 high performance liquid chromatography Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Natural Medicines & Medicinal Plants (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Mycology (AREA)
Botany (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

AT08720152T 2007-02-12 2008-02-11 Zusammensetzung für selektive hemmung der serotoninwiederaufnahme und verfahren dafür ATE495749T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN255MU2007		2007-02-12
PCT/IN2008/000132 WO2008099426A1 (en)	2007-02-12	2008-02-11	A composition for selective serotonin reuptake inhibition and process thereof

Publications (1)

Publication Number	Publication Date
ATE495749T1 true ATE495749T1 (de)	2011-02-15

Family

ID=39402592

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08720152T ATE495749T1 (de)	2007-02-12	2008-02-11	Zusammensetzung für selektive hemmung der serotoninwiederaufnahme und verfahren dafür

Country Status (12)

Country	Link
US (1)	US9669043B2 (de)
EP (1)	EP2117560B1 (de)
JP (1)	JP5266254B2 (de)
KR (1)	KR101183045B1 (de)
CN (1)	CN101652143B (de)
AT (1)	ATE495749T1 (de)
AU (1)	AU2008215743B2 (de)
BR (1)	BRPI0806793B8 (de)
CA (1)	CA2677872C (de)
DE (1)	DE602008004625D1 (de)
ES (1)	ES2358306T3 (de)
WO (1)	WO2008099426A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103079573B (zh)	2010-06-10	2016-06-15	梧桐生物技术私人有限公司	用于由积雪草制备高纯度积雪草苷组合物的方法及其应用方法
FR2964570A1 (fr) *	2010-09-09	2012-03-16	Burgundy	Procede de preparation d'un extrait de centella asiatica
CN101983966B (zh) *	2010-11-19	2012-08-15	浙江大学	低积雪草苷含量总苷出发同时制备积雪草苷和羟基积雪草苷的工艺
CN103596573B (zh) *	2011-06-02	2016-04-06	梧桐生物技术私人有限公司	处理高皮质醇血症、头痛失调、神经性疼痛及相关失调的方法
JP7538599B2 (ja) *	2016-07-17	2024-08-22	ワンネス・バイオテック・カンパニー・リミテッド	創傷治癒を促進するための局所製剤
CN108002997B (zh) *	2017-12-15	2020-10-23	中国医学科学院药用植物研究所海南分所	一种具有止呕作用的沉香提取物及其应用
CN111329866B (zh) *	2020-04-12	2023-04-07	云南民族大学	一种五环三萜类化合物在制备抗偏头痛药物中的应用
US20230212121A1 (en)	2020-05-29	2023-07-06	Daegu-Gyeongbuk Medical Innovation Foundation	Sulfonamide derivative and pharmaceutical composition comprising same as active ingredient for preventing or treating mental illness
WO2021241876A1 (ko)	2020-05-29	2021-12-02	재단법인 대구경북첨단의료산업진흥재단	카복사미드 유도체 및 이를 유효성분으로 함유하는 정신질환의 예방 또는 치료용 약학적 조성물
JP7580849B2 (ja)	2020-05-29	2024-11-12	トリニューロ	少なくとも１つのｎを含む５員ヘテロアリール誘導体、ならびにこれを有効成分として含有する精神障害の予防または治療に使用するための医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0383171A3 (de)	1989-02-11	1991-07-24	Hoechst Aktiengesellschaft	2,3,23-Trihydroxy-urs-12-en Derivate zur Behandlung von Kognitiven Störungen
KR100228873B1 (ko) *	1997-03-24	1999-11-01	강재헌	센텔라아시아티카에서 분리한 아시아티코사이드와 마테카소 사이드의 수용성 추출물을 함유한 간세포 및 항간섬유화 치료제
JP4497566B2 (ja) *	1998-09-02	2010-07-07	株式会社日本薬用食品研究所	アルドース還元酵素阻害剤並びに新規サポニン及び新規サポゲノール
CN1211098C (zh) *	2001-05-29	2005-07-20	中国人民解放军第二军医大学	积雪草总甙抗抑郁症的用途
JP2004002335A (ja) *	2002-03-28	2004-01-08	Ortho Corporation	不定愁訴症状改善剤及び食品とその組成物
CN1121862C (zh) *	2002-04-16	2003-09-24	中国人民解放军第二军医大学	羟基积雪草甙用于制备治疗抑郁症药物的用途
FR2848117B1 (fr) *	2002-12-10	2006-08-04	Roche Consumer Health Ltd	Procede de preparation d'un extrait de centella asiatica riche en madecassoside et en terminoloside
CN100467025C (zh) *	2004-06-09	2009-03-11	北京苏里曼医药科技有限公司	积雪草总苷、积雪草苷或羟基积雪草苷在制备防治心、脑血管疾病药物中的用途
CN1583127A (zh) *	2004-06-11	2005-02-23	张正生	一种治疗抑郁症和肿瘤的中药制剂及其制备方法
CN100441201C (zh) *	2005-06-08	2008-12-10	浙江省医学科学院	含积雪草水溶性有效组分的中药缓释制剂及其制备方法

2008
- 2008-02-11 EP EP08720152A patent/EP2117560B1/de active Active
- 2008-02-11 BR BRPI0806793A patent/BRPI0806793B8/pt active IP Right Grant
- 2008-02-11 AT AT08720152T patent/ATE495749T1/de not_active IP Right Cessation
- 2008-02-11 CA CA2677872A patent/CA2677872C/en active Active
- 2008-02-11 JP JP2009548800A patent/JP5266254B2/ja active Active
- 2008-02-11 AU AU2008215743A patent/AU2008215743B2/en active Active
- 2008-02-11 DE DE602008004625T patent/DE602008004625D1/de active Active
- 2008-02-11 ES ES08720152T patent/ES2358306T3/es active Active
- 2008-02-11 KR KR1020097016796A patent/KR101183045B1/ko active Active
- 2008-02-11 CN CN2008800086984A patent/CN101652143B/zh active Active
- 2008-02-11 WO PCT/IN2008/000132 patent/WO2008099426A1/en not_active Ceased
- 2008-02-12 US US12/069,766 patent/US9669043B2/en active Active

Also Published As

Publication number	Publication date
CA2677872A1 (en)	2008-08-21
CA2677872C (en)	2012-04-03
KR20090117736A (ko)	2009-11-12
EP2117560B1 (de)	2011-01-19
CN101652143B (zh)	2013-11-06
DE602008004625D1 (de)	2011-03-03
ES2358306T3 (es)	2011-05-09
BRPI0806793B8 (pt)	2021-05-25
US9669043B2 (en)	2017-06-06
AU2008215743B2 (en)	2010-10-07
JP5266254B2 (ja)	2013-08-21
BRPI0806793B1 (pt)	2021-03-09
JP2010530841A (ja)	2010-09-16
US20080194499A1 (en)	2008-08-14
EP2117560A1 (de)	2009-11-18
AU2008215743A1 (en)	2008-08-21
BRPI0806793A2 (pt)	2011-09-13
KR101183045B1 (ko)	2012-09-20
WO2008099426A1 (en)	2008-08-21
CN101652143A (zh)	2010-02-17

Legal Events

Date	Code	Title	Description
2011-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE602008004625D1 (de)	2011-03-03	Zusammensetzung für selektive hemmung der serotoninwiederaufnahme und verfahren dafür
Tariq et al.	2015	Review on ethnomedicinal, phytochemical and pharmacological evidence of Himalayan anticancer plants
BRPI0715018A2 (pt)	2013-11-26	Extrato derivado de cana de açúcar, produto alimenticio, preparação para uso como produto farmacêutico,cosmético, processo de produção de extratos derivados de cana de açúcar e método de refino de um extrato fitoquímico
HK1247856A1 (zh)	2018-10-05	羟丙基β-环糊精组合物及方法
WO2009081211A3 (en)	2009-10-29	Composition and method
WO2009093255A3 (en)	2009-12-30	A new nutraceutical composition from garcinia mangostana
WO2010134100A3 (en)	2011-01-27	Method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants
CN108653368A (zh)	2018-10-16	一种珊瑚树萜类成分的制备方法
TW200740447A (en)	2007-11-01	Pharmaceutical composition for treating inflammation, pain, arthritis and spinitis, and proliferating osteoblastic cell and method thereof
Tian et al.	2015	Chemical constituents of Portulaca oleracea
Rezazadeh et al.	2005	Anti-inflammatory and analgesic activity of methanolic extracts of aerial parts of stachys schtschegleevii sosn. and stachys balansae boiss. and kotschy ex boiss in rats
CN104815002A (zh)	2015-08-05	一种宽筋藤提取物的获得方法及其应用
Su et al.	2007	Studies on chemical constituents from stems and leaves of Adenanthera pavanina
MX2014010926A (es)	2015-04-10	Composicion herbaria para el tratamiento de transtornos metabolicos.
Das et al.	2016	Available online at
WO2011065699A3 (ko)	2011-09-29	백미증법을 이용한 한방성분 추출방법
Choi et al.	2008	Ameliorating effect of balloon flower saponin on the ethanol‐induced memory impairment in mice
Jiang	2015	Study on chemical constituents of Lonicera japonica bud
MX2010002982A (es)	2010-08-31	Combretum laurifolium mart. extracto y metodos de extraccion y uso de dicho extracto.
ES2324584B1 (es)	2010-04-22	Formulacion farmaceutica para el tratamiento del sindrome de inmunodeficiencia humana (sida) y procedimiento de obtencion de dicha formulacion.
BRPI1006987A2 (pt)	2016-04-12	extrato de cissampelos pareira, uso do mesmo, processo para o preparo do mesmo, fração, composição farmacêutica e método para o tratamento de infecção pelo vírus da dengue.
CN105037465B (zh)	2018-08-21	一种从百里香属植物中得到的灯盏乙素
Xu et al.	2015	Study on chemical constituents from ethyl acetate extraction of Sanicula lamelligera
EP1732875B1 (de)	2013-05-15	Verfahren zur isolierung des lebenschützenden mittels oleanolsäure aus lantana camara
Qin et al.	2007	Studies on chemical constituents of Heterosmilax yunnanensis